Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.
You must be a subscriber to access all of this content.
The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family's representation.
You must be a subscriber to access all of this content.
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
You must be a subscriber to access all of this content.
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
You must be a subscriber to access all of this content.
Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.
You must be a subscriber to access all of this content.
PEPFAR cuts have been linked to a 45% decline in South African children receiving HIV treatment at US-supported healthcare sites.
You must be a subscriber to access all of this content.